The LatAm‑FINGERS trial shows a structured lifestyle program can improve brain health in at‑risk older Latin Americans, pointing to a scalable dementia‑prevention market in the region
Executive summary: The LatAm‑FINGERS study, presented at the 2026 Alzheimer’s Association International Conference, reported that a structured lifestyle program improved brain health markers in older Latin American adults at risk for dementia. It provides the first large‑scale evidence that dementia‑risk reduction strategies validated in the US POINTER trial can be adapted across diverse Latin American cultures and health systems.
Who is involved: Researchers from the Alzheimer’s Association, local Latin American health institutions, and participants aged 60+ from Brazil, Mexico, Colombia, and Chile.
Likely next: Study data will be prepared for peer‑review publication later in 2026, and the Alzheimer’s Association plans to expand the program to additional countries in 2027.
The study, presented at the 2026 Alzheimer’s Association International Conference, compared a multi‑component lifestyle intervention (diet, exercise, cognitive training, vascular monitoring) against usual care in older adults from Brazil, Mexico, Colombia and Chile. Participants in the intervention group demonstrated statistically significant improvements in composite cognitive scores and biomarkers of brain health after two years. These findings reinforce that the risk‑reduction strategy proven in the US POINTER trial can be adapted to diverse Latin American health systems and cultural contexts.
Timeline
- — FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2026 LIFESTYLE PROGRAM IMPROVES BRAIN HEALTH AMONG OLDER ADULTS AT RISK FOR DEMENTIA ACROSS LATIN AMERICA (PR Newswire)
Analysis — what this means
Likely next events
- LatAm‑FINGERS study results to be submitted for peer‑review publication by Q4 2026.
- Alzheimer's Association PROTECT‑COG study to begin participant enrollment in Q3 2026.
- AAIC 2026 conference continues through July 15, 2026 with additional sessions on dementia prevention.
Sectors affected
- Latin American senior wellness and assisted living sector
- Digital cognitive health platforms targeting Spanish‑ and Portuguese‑speaking older adults
- Nutraceutical and supplement market for brain health in Latin America
Historical parallels
- Finnish FINGER trial (2012‑2014) showed lifestyle intervention reduced cognitive decline by ~30% over two years.
- US POINTER trial (2020‑2024) demonstrated similar dementia‑risk reduction in a multicultural US cohort.
Key entities
Sources
Open the full interactive case file on Beyond →
Social Pulse
AI estimate · not scraped